Kingworld Medicines Group Limited

SEHK:1110 株式レポート

時価総額:HK$337.7m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Kingworld Medicines Group マネジメント

マネジメント 基準チェック /34

現在、CEO に関する十分な情報がありません。

主要情報

Li Sheng Zhao

最高経営責任者

CN¥1.5m

報酬総額

CEO給与比率98.5%
CEO在任期間15.8yrs
CEOの所有権54.1%
経営陣の平均在職期間データなし
取締役会の平均在任期間14.2yrs

経営陣の近況

Recent updates

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

May 31
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

May 22
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Apr 29
Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Apr 23
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Mar 22
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Nov 30
The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Aug 17
Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

May 30
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

May 11
The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Apr 03
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

Feb 07
Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Oct 07
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Jul 05
Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

Apr 27
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Aug 17
We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Apr 24
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Mar 29
Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Mar 08
Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Feb 15
Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Jan 25
Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

Dec 18
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

Dec 05
We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Nov 22
What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

CEO報酬分析

Kingworld Medicines Group の収益と比較して、Li Sheng Zhao の報酬はどのように変化したか?
日付総報酬給与会社業績
Dec 31 2023CN¥1mCN¥1m

CN¥38m

Sep 30 2023n/an/a

CN¥37m

Jun 30 2023n/an/a

CN¥36m

Mar 31 2023n/an/a

CN¥29m

Dec 31 2022CN¥1mCN¥1m

CN¥23m

Sep 30 2022n/an/a

CN¥29m

Jun 30 2022n/an/a

CN¥35m

Mar 31 2022n/an/a

CN¥33m

Dec 31 2021CN¥1mCN¥1m

CN¥30m

Sep 30 2021n/an/a

CN¥26m

Jun 30 2021n/an/a

CN¥21m

Mar 31 2021n/an/a

CN¥17m

Dec 31 2020CN¥1mCN¥1m

CN¥12m

Sep 30 2020n/an/a

CN¥16m

Jun 30 2020n/an/a

CN¥20m

Mar 31 2020n/an/a

CN¥32m

Dec 31 2019CN¥2mCN¥2m

CN¥43m

Sep 30 2019n/an/a

CN¥45m

Jun 30 2019n/an/a

CN¥46m

Mar 31 2019n/an/a

CN¥44m

Dec 31 2018CN¥1mCN¥1m

CN¥41m

Sep 30 2018n/an/a

CN¥49m

Jun 30 2018n/an/a

CN¥56m

Mar 31 2018n/an/a

CN¥54m

Dec 31 2017CN¥2mCN¥1m

CN¥51m

報酬と市場: Li Shengの 総報酬 ($USD 200.25K ) は、 Hong Kong市場 ($USD 233.13K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Li Shengの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Li Sheng Zhao (66 yo)

15.8yrs

在職期間

CN¥1,452,000

報酬

Mr. Li Sheng Zhao is a Co-founder of Kingworld Medicines Group Limited and serves as its Chief Executive Officer. Mr. Zhao is responsible for Kingworld Medicines Group's overall strategic planning and busi...


取締役

名称ポジション在職期間報酬所有権
Li Sheng Zhao
Co-Founder15.8yrsCN¥1.45m54.1%
CN¥ 182.7m
Lok San Chan
Co-Founder & Executive Director15.8yrsCN¥1.32m15.24%
CN¥ 51.5m
Xuhua Zhou
Executive Director14.8yrsCN¥483.00k0.45%
CN¥ 1.5m
Cheuk Lam Wong
Independent Non-Executive Director13.6yrsCN¥285.00k0.036%
CN¥ 120.8k
Jidong Duan
Independent Non-Executive Director13.6yrsCN¥285.00kデータなし
Jianbin Zhang
Independent Non-Executive Director10.8yrsCN¥285.00k0.042%
CN¥ 141.4k

14.2yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: 1110の 取締役会 は経験豊富で 経験豊富 です ( 14.2年の平均在任期間)。